Results 191 to 200 of about 355,709 (346)

B cell-associated research in non-small cell lung cancer: a bibliometric analysis of current landscapes and future directions. [PDF]

Discov Oncol
Zhang Y, Chen X, Mai W, Wang L, Wang Y, Ma C, Li H.   +6 more
europepmc   +1 more source

Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution

International Journal of Cancer, EarlyView.
Abstract Prostate cancer is a common malignancy that in 5%–30% leads to treatment‐resistant and highly aggressive disease. Metastasis‐potential and treatment‐resistance is thought to rely on increased plasticity of the cancer cells—a mechanism whereby cancer cells alter their identity to adapt to changing environments or therapeutic pressures to create
Kira Furlano, Tina Keshavarzian, Nadine Biernath, Annika Fendler, Maria de Santis, Joachim Weischenfeldt, Mathieu Lupien   +6 more
wiley   +1 more source

ZNF184-mediated transcriptional activation of SAE1 drives the cell cycle entry and immune evasion in non-small cell lung cancer. [PDF]

Respir Res
Shi F, Zhang L, Wang C, Meng Q.
europepmc   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

RTOG 9705, a phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIA non-small cell lung cancer (NSCLC) patients — promising long term survival results [PDF]

, 2003
Mary V. Graham, Rebecca Paulus, David S. Ettinger, Jeffrey D. Bradley, M.V. Pilepich, Mitchell Machtay, Ritsuko Komaki, JN Atkins, Walter J. Curran, Charles Scott   +9 more
openalex   +1 more source

Clinical and economic impact of recurrence in unresected non-small cell lung cancer treated with primary stereotactic body radiotherapy: A real-world study using SEER-Medicare data. [PDF]

J Manag Care Spec Pharm
Rai P, Song A, Zhang S, Song Y, Gao C, Jiang A, Li J, Jiang P, Signorovitch J, Arunachalam A, Samkari A, Daly ME.   +11 more
europepmc   +1 more source

Early pembrolizumab clearance as prognostic biomarker for non‐response in patients with advanced non‐small cell lung cancer

International Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors have improved survival rates in patients with advanced‐stage non‐small cell lung cancer; however, the majority obtain no long‐term benefits. This analysis derived from two prospective clinical studies indicates that lean body weight‐normalized clearance of pembrolizumab is a highly sensitive biomarker for the ...
Fenna de Vries, Leila‐Sophie Otten, Berber Piet, Eric J. F. Franssen, Arthur A. J. Smit, Michel M. van den Heuvel, Rob ter Heine, The DEDICATION‐1 Study Group, Marijn Smits‐Zwinkels, Erica Geraedts, Jeske Staal‐van den Brekel, Yvonne Berk, Femke van der Meer, Niels Claessens, Bianca van Veggel, Lizza Hendriks, Wouter Jacobs, Annette Bijsmans, Arthur Mulders, Cor van der Leest, Joost Jansen, Wouter van Geffen, Quincy de Waard, Maggy Youssef, Wai Yee Lam‐Wong, Keetie van Loenhout, Daphne Dumoulin, Suzi Samii, Svitlana Tarasevych, Christi Steendam, Vivian van Kampen‐van den Boogaart, Judith Herder, Ernst Lammers, T. Jeroen N. Hiltermann, Nicole Barlo, Emanual Citgez, Antoinette Kroeze   +36 more
wiley   +1 more source

ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases [PDF]

, 2003
Federico Cappuzzo, C. Calandri, Stefania Bartolini, Lucio Crinò   +3 more
openalex   +1 more source

Unraveling the molecular-pathological characteristics and cellular complexity of the tumor immune microenvironment in metastatic non-small cell lung cancer. [PDF]

Cell Commun Signal
Bharadwaj S, Mierzwicka JM, Vaňková L, Malý P.   +3 more
europepmc   +1 more source

Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients

International Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu, Qiuhong Zhang, Jie Gao, Shiyuan Yao, Chan Tian, Tuo He, Ming Zhang, Hu Shan, Jie Shi, Bo Yuan, Lei Wang, Xia Yang   +11 more
wiley   +1 more source